Clinical Trial Update: Melatonin for Prevention of Delirium in Critically Ill Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating melatonin for prevention of delirium in critically ill patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Delirium | Phase 2 | Status: UNKNOWN